Single-course methotrexate and single-course combined methotrexate-dactinomycin: A phase III randomized controlled clinical trial in treatment of low-risk gestational trophoblastic neoplasm
第一作者单位:[1]Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Zhejiang, Peoples R China
推荐引用方式(GB/T 7714):
Chen L.,Yin R.,Xi L.,et al.Single-course methotrexate and single-course combined methotrexate-dactinomycin: A phase III randomized controlled clinical trial in treatment of low-risk gestational trophoblastic neoplasm[J].GYNECOLOGIC ONCOLOGY.2018,149:20-20.doi:10.1016/j.ygyno.2018.04.051.
APA:
Chen, L.,Yin, R.,Xi, L.,Jiang, J.,Li, X....&Lv, W..(2018).Single-course methotrexate and single-course combined methotrexate-dactinomycin: A phase III randomized controlled clinical trial in treatment of low-risk gestational trophoblastic neoplasm.GYNECOLOGIC ONCOLOGY,149,
MLA:
Chen, L.,et al."Single-course methotrexate and single-course combined methotrexate-dactinomycin: A phase III randomized controlled clinical trial in treatment of low-risk gestational trophoblastic neoplasm".GYNECOLOGIC ONCOLOGY 149.(2018):20-20